Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Circulating MicroRNAs as Biomarkers in Diffuse Large B-cell Lymphoma: A Pilot Prospective Longitudinal Clinical Study.

Bouvy C, Wannez A, George F, Graux C, Chatelain C, Dogné JM.

Biomark Cancer. 2018 Jun 18;10:1179299X18781095. doi: 10.1177/1179299X18781095. eCollection 2018.

2.

Clean Colorectum at Diagnostic Colonoscopy: Subsequent Detection of Extracolonic Malignancies by Plasma Protein Biomarkers?

Wilhelmsen M, Christensen IJ, Jørgensen LN, Madsen MR, Vilandt J, Hillig T, Klærke M, Nielsen KT, Laurberg S, Gawel S, Yang X, Davis G, Heijboer AM, Martens F, Nielsen HJ.

Biomark Cancer. 2018 May 30;10:1179299X18776974. doi: 10.1177/1179299X18776974. eCollection 2018.

3.

Data Mining of Small RNA-Seq Suggests an Association Between Prostate Cancer and Altered Abundance of 5' Transfer RNA Halves in Seminal Fluid and Prostatic Tissues.

Dhahbi JM, Atamna H, Selth LA.

Biomark Cancer. 2018 Feb 20;10:1179299X18759545. doi: 10.1177/1179299X18759545. eCollection 2018.

4.

Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer.

Su J, Leng Q, Lin Y, Ma J, Jiang F, Lee CJ, Fang H, Jiang F.

Biomark Cancer. 2018 Feb 13;10:1179299X18759297. doi: 10.1177/1179299X18759297. eCollection 2018.

5.

HumanMethylation450K Array-Identified Biomarkers Predict Tumour Recurrence/Progression at Initial Diagnosis of High-risk Non-muscle Invasive Bladder Cancer.

Kitchen MO, Bryan RT, Emes RD, Luscombe CJ, Cheng KK, Zeegers MP, James ND, Gommersall LM, Fryer AA.

Biomark Cancer. 2018 Jan 8;10:1179299X17751920. doi: 10.1177/1179299X17751920. eCollection 2018.

6.

Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma.

Mehra M, Chauhan R.

Biomark Cancer. 2017 Nov 2;9:1179299X17737301. doi: 10.1177/1179299X17737301. eCollection 2017. Review.

7.

More Accurate Oral Cancer Screening with Fewer Salivary Biomarkers.

Menke JM, Ahsan MS, Khoo SP.

Biomark Cancer. 2017 Oct 17;9:1179299X17732007. doi: 10.1177/1179299X17732007. eCollection 2017.

8.

In Search for Optimal Targets for Intraoperative Fluorescence Imaging of Peritoneal Metastasis From Colorectal Cancer.

Hoogstins CE, Weixler B, Boogerd LS, Hoppener DJ, Prevoo HA, Sier CF, Burger JW, Verhoef C, Bhairosingh S, Farina Sarasqueta A, Burggraaf J, Vahrmeijer AL.

Biomark Cancer. 2017 Aug 28;9:1179299X17728254. doi: 10.1177/1179299X17728254. eCollection 2017.

9.

Analysis of Fascin-1 in Relation to Gleason Risk Classification and Nuclear ETS-Related Gene Status of Human Prostate Carcinomas: An Immunohistochemical Study of Clinically Annotated Tumours From the Wales Cancer Bank.

Jefferies MT, Pope CS, Kynaston HG, Clarke AR, Martin RM, Adams JC.

Biomark Cancer. 2017 May 30;9:1179299X17710944. doi: 10.1177/1179299X17710944. eCollection 2017.

10.

Correlation Between Preoperative Serum Carcinoembryonic Antigen Levels and Expression on Pancreatic and Rectal Cancer Tissue.

Boogerd LSF, Vuijk FA, Hoogstins CES, Handgraaf HJM, van der Valk MJM, Kuppen PJK, Sier CFM, van de Velde CJH, Burggraaf J, Fariña-Sarasqueta A, Vahrmeijer AL.

Biomark Cancer. 2017 May 17;9:1179299X17710016. doi: 10.1177/1179299X17710016. eCollection 2017.

11.

Biomarkers for Hepatocellular Carcinoma.

Lou J, Zhang L, Lv S, Zhang C, Jiang S.

Biomark Cancer. 2017 Feb 28;9:1-9. doi: 10.1177/1179299X16684640. eCollection 2017. Review.

12.

Preoperative Serum Carcinoembryonic Antigen as a Marker for Predicting the Outcome of Three Cancers.

Nan J, Li J, Li X, Guo G, Wen X, Tian Y.

Biomark Cancer. 2017 Feb 16;9:1-7. doi: 10.1177/1179299X17690142. eCollection 2017.

13.

miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma.

Chen Z, Yu T, Cabay RJ, Jin Y, Mahjabeen I, Luan X, Huang L, Dai Y, Zhou X.

Biomark Cancer. 2017 Jan 9;9:1-8. doi: 10.4137/BIC.S40981. eCollection 2017.

14.

Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins.

Boonstra MC, de Geus SW, Prevoo HA, Hawinkels LJ, van de Velde CJ, Kuppen PJ, Vahrmeijer AL, Sier CF.

Biomark Cancer. 2016 Sep 27;8:119-133. eCollection 2016. Review.

15.

Association of MTHFR (C677T) Gene Polymorphism With Breast Cancer in North India.

Waseem M, Hussain SR, Kumar S, Serajuddin M, Mahdi F, Sonkar SK, Bansal C, Ahmad MK.

Biomark Cancer. 2016 Sep 27;8:111-117. eCollection 2016.

16.

PET Metabolic Biomarkers for Cancer.

Croteau E, Renaud JM, Richard MA, Ruddy TD, Bénard F, deKemp RA.

Biomark Cancer. 2016 Sep 20;8(Suppl 2):61-9. doi: 10.4137/BIC.S27483. eCollection 2016. Review.

17.

Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition.

Fernandes J.

Biomark Cancer. 2016 Jul 28;8:101-10. doi: 10.4137/BIC.S33378. eCollection 2016. Review.

18.

Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR Images.

Eilaghi A, Yeung T, d'Esterre C, Bauman G, Yartsev S, Easaw J, Fainardi E, Lee TY, Frayne R.

Biomark Cancer. 2016 Jul 3;8(Suppl 2):47-59. doi: 10.4137/BIC.S31801. eCollection 2016. Review.

19.

Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma.

Chauhan R, Lahiri N.

Biomark Cancer. 2016 Jul 4;8(Suppl 1):37-55. doi: 10.4137/BIC.S34413. eCollection 2016. Review.

20.

Predicting Clinical Outcomes Using Molecular Biomarkers.

Burke HB.

Biomark Cancer. 2016 Jun 6;8:89-99. doi: 10.4137/BIC.S33380. eCollection 2016. Review.

Supplemental Content

Loading ...
Support Center